Pulmonary Function Testing (PFT) is an essential tool in the diagnosis and management of respiratory diseases. However, the interpretation of these tests can be complex, requiring a comprehensive understanding of respiratory physiology. This article aims to provide a concise guide to PFT interpretation for healthcare professionals.
Standard PFTs comprise of spirometry, lung volumes, and diffusion capacity. Spirometry measures the volume and speed of air that can be inhaled and exhaled, providing vital information on airflow limitation. Lung volumes assess the total capacity of the lungs, while diffusion capacity evaluates the efficiency of gas transfer from the lungs to the blood.
Spirometry results are interpreted by comparing the patient's values to predicted normal values. A reduced ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) suggests obstructive disease, such as asthma or COPD. A reduced FEV1 and FVC with a normal FEV1/FVC ratio points towards restrictive disease, like pulmonary fibrosis.
Lung volumes can provide additional information when spirometry is inconclusive. An increased residual volume (RV) can indicate air trapping, common in obstructive diseases. A reduced total lung capacity (TLC) is suggestive of restrictive disease. The diffusion capacity of the lung for carbon monoxide (DLCO) is useful in diagnosing and monitoring conditions that affect gas exchange, such as emphysema or pulmonary hypertension.
PFT interpretation is a critical skill for healthcare professionals involved in respiratory care. A systematic approach to interpreting spirometry, lung volumes, and diffusion capacity can facilitate accurate diagnosis and guide treatment decisions. Continuing education and practical experience are key to mastering PFT interpretation.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation